Download FREE Report Sample
Download Free samplePsychedelic Drugs Market contains market size and forecasts of Psychedelic Drugs in Global, including the following market information:
Global Psychedelic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Psychedelic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Psilocybin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Psychedelic Drugs include COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS and MindMed, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psychedelic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychedelic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Psychedelic Drugs Market Segment Percentages, by Type, 2021 (%)
Psilocybin
LSD
MDMA
DMT
Ketamine
Others
Global Psychedelic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Psychedelic Drugs Market Segment Percentages, by Application, 2021 (%)
Depressive Disorders
Post-Traumatic Stress Disorders
Substance Abuse Disorders
Obsessive Compulsive Disorders
Others
Global Psychedelic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Psychedelic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychedelic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Psychedelic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
